Clinical trial
Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood…
NCT00184678 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184678 |
|---|---|
| Title | Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency |
| Official title | Effect of Two Years of Treatment With Norditropin® SimpleXx® on Bone Mineral Density in Young Adults With Childhood-Onset Growth Hormone Deficiency |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Hormone Disorder, Adult Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 161 |
| Start date | Feb 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 13, 2017 |
| Countries | Australia, Austria, Belgium, France, Germany, Hungary, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: